Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 19, 2024
July 25, 2024
f199b979-79a2-47a4-99e4-b55e181a268d
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentOctober 26, 2017Center for Drug Evaluation and Research
Crohn’s Disease: Developing Drugs for Treatment
Guidance DocumentApril 28, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox